期刊文献+

不同类型炎症中白细胞介素诸细胞因子水平变化及意义 被引量:4

Clincial significance of plasma levels of inflammatory factors in different kind of imflamatory response
原文传递
导出
摘要 目的研究感染性和自身免疫性炎症中白细胞介素(IL)诸细胞因子IL-1、IL-2、IL-6、IL-8、IL-12、IL-18和IL-4、IL-10、IL-13水平变化及变化持续时间的差异及其意义。方法应用放射性免疫法及双抗体夹心酶联免疫吸附法于不同时间检测感染性炎症75例(感染组)和自身免疫性炎症74例(自身免疫组)患者血清各因子含量值共8次,比较各因子变化情况及变化持续时间。结果IL-1、IL-2、IL-6、IL-8、IL-12、IL-18因子在两组差异有统计学意义(均P〈0.05)。入院2周后,感染组各因子检测水平开始降低并逐渐恢复至正常水平;自身免疫组多数因子则不能恢复至正常水平;两组各因子异常持续时间比较差异有统计学意义(P〈0.05)。IL-4、IL-10、IL-13因子在两组中差异有统计学意义(均P〈0.05)。入院1—2周后,感染组各因子检测水平开始降低并逐渐恢复至正常水平,自身免疫组不能恢复到正常水平,2组间异常持续时间差异有统计学意义(均P〈0.05)。结论细胞因子异常变化水平,特别是异常波动时间与炎症的性质及结局可能有内在因果关系。 Objective To evaluate the clinical significance of the levels and duration of elvafion of the interleukins (IL-1 ; IL-2 ; IL-6 ; IL-8 ; IL-12 ; IL-18 ) and ( IL-4 ; IL-10 ; IL-13 ) in two different types of inflammatory response. Methods The interleukins were measured by ELISA in 149 patients for eight times in different period. Resuits The interleukins levels of inflammatory eytokines showed the significant difference between groups ( P 〈 0.05 ). After two weeks of admission, the levels of interleukins of infection group could return to normol gradually, those of the autoimmunities group could not. There was significant difference for rising duration of interleukins between two groups (P 〈 0.05 ). There was singnificant difference for interleukins level of anti-inflammatory cytokines between two groups ( P 〈 0.05 ). After one or two weeks of admission, the levels of interleukins of infection group could return to normol gradually, and those of the autoimmunitie group could not. There was significant difference for rising duration of interleukins between two groups ( P 〈 0.05 ). Conclusion There maybe a causal relation among the abnormal cytokines levels especially the abnormal rising duration and inflammatory nature as well as outcome.
出处 《中国综合临床》 北大核心 2008年第3期244-247,共4页 Clinical Medicine of China
关键词 自身免疫性疾病 感染性疾病 白细胞介素 Infectious disease Autoimmunity disease Interleukin
  • 相关文献

参考文献12

  • 1陈灏珠.实用内科学[M].11版.北京:人民卫生出版社,2004:1154.
  • 2Stanley L, Robbins MD, Rumzl S, et al. The Pathologic Basis of Disease[ M ]. London : W Bsaunders Company, 1979.55-90.
  • 3钱齐宏,张学光,殷昌硕,顾宗江,邱玉华,王宝涛,刘铭,杨晓惠.系统性红斑狼疮患者外周血白介素2和白介素6及其受体的研究[J].中华皮肤科杂志,2003,36(12):696-698. 被引量:9
  • 4Calandra T, Echtenacher B. Roy DL, et al. Protection from septic shock by neutralization of macrophage migration inhibitory factor [J]. Nat Med,2000,6(2) :164-170.
  • 5Crabtree GR. Contiongent genetic regulatory events in T lymphocyte activation [ J ]. J Inmmunol, 1994,152 (3) : 1228.
  • 6彭群新,顾国浩,陈爱明.SLE患者外周血单个核细胞分泌IL-4、IL-10、IL-12和IFN-γ水平及意义[J].西安交通大学学报(医学版),2005,26(6):602-603. 被引量:2
  • 7黎莉,陈顺乐,沈南,王晓栋,鲍春德,顾越英.初发系统性红斑狼疮患者Th1/Th2及其调控因子IL-10IL-12基因研究[J].中华风湿病学杂志,2002,6(1):13-17. 被引量:12
  • 8John FM,Wu CY,Rober AS,et al. The regulation of the IL-12,its role in infectious, auto mmune, and allergic disease[J]. Allergy Clin Immunol,1998,102( 1 ) :1115.
  • 9Liu TF,Jones BM. Imparied production of IL-12 in systemic lupus erythematosus. Ⅱ ,IL-12 production in vitro is correlation negatively with serum IL-10 ,positively with serum IFN-γ/ and negatively with disease activity in SLE [ J ]. Cytokine ,1998,10 (5) : 148.
  • 10Grondal G, Kristjansdottir H, Gunnlaugsdottir B, et al. Increased number of interleukin-10-producing cells in systemic lupus erythematosus patients and their first degree relatives and spouse in lcelandic multicase familes [ J ]. Arthritis Rheum, 1999,12 ( 7 ) : 1649 - 1654.

二级参考文献26

  • 1胡大伟 陈顺乐 石学耕 等.Th1/Th2细胞因子的失衡与狼疮活动性的研究[J].中华风湿病学杂志,1999,3(1):8-11.
  • 2Yin JL,Shackel NA,Zekry A,et al.Real-time reverse transcriptase-polymerase chainreaction (RT-PCR) for measurement of cytokine and growth factor mRNA expression withfluorogenic probes or SYBR Green I.Immunol Cell Biol,2001,79:213-221.
  • 3Funauchi M,Ikoma S,Enomoto H,et al.Decreased Th1-like and increased Th2-like cellsin systemic lupus erythematosus.Scand J Rheumatol,1998,27:219-224.
  • 4Akahosi M,Nakashima H,Tanaka Y,et al.Th1/Th2 balance of peripheral T helper cellsin systemic lupus erythematosus.Arthritis Rheum,2000,43:711-712.
  • 5Takahashi S,Fossati L,Iwamoto M,et al.Imbalance towards Th1 predominance isassociated with acceleration of lupus-like autoimmune sydrom in MRL mice.J ClinInvest,1996,97:1597-1604.
  • 6Alleva DG,Kaser SB,Beller DI.Intrinsic defects in macrophage IL-12 productionassociated with immune dysfunction in the MRL/ and New Zealand Black/White F1lupus-prone mice and the Leishmania major-susceptible BALB/c strain.JImmunol,1998,161:6878-6884.
  • 7Dayan M,Segal R,Mozes E.Cytokine manipulation by methotrexate treatment in murineexperimental systemic lupus erythematosus.J Rheumatol,1997,24:1075-1082.
  • 8Heloisa BM,Dekruyff RH,Umetsu DT.Corticosteroids enhance the capacity ofmacrophages to induce Th2 cytokine synthesis in CD4+ lymphocytes by inhabiting IL-12production.J Immunol,1998,160:2231-2237.
  • 9Cross JT,Benton HP.The roles of IL-6 and IL-10 in B cell hyperactivity inSLE.Inflamm Res,1999,48:255-261.
  • 10Rogge L,Bianch E,Biffi M,et al.Transcript imaging of the development of human Thelper cells using oligonucleotide arrays.Nature Genetics,2000,25:96-100.

共引文献45

同被引文献45

引证文献4

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部